Better shared decision-making could help patients feel more empowered, avoid treatment side-effects and reduce overtreatment.
Ian Demsky is a senior writer and public relations representative for the University of Michigan Rogel Cancer Center. Ian joined the cancer center communications team in 2019. Prior to that he served as director of communications for the U-M Life Sciences Institute and science editor for Medicine at Michigan Magazine.
Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.
Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.
A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment
A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.
A new approach to RNA sequencing reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers.